Safety and Efficacy of KRP203 in Subacute Cutaneous Lupus Erythematosus
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
This study will assess the safety and efficacy of KRP203 in clinically active subacute
cutaneous lupus erythematosus patients, who have demonstrated inadequate response to standard
treatment, such as antimalarials.